Skip to Main Content

COVID-19 Fund to Retain Clinical Scientists

We are writing to announce a request for applications for supplemental research support from early-career physician-scientists who face significant caregiving demands. The goal of the program is to retain such scientists in the research enterprise. Funding is provided by the COVID-19 Fund to Retain Clinical Scientists at Yale School of Medicine (COVID-19 FRCS) funded by the Doris Duke Charitable Foundation through the COVID-19 Fund to Retain Clinical Scientists collaborative and the Yale School of Medicine. Our process will consider the degree of demonstrated caregiving burden and prioritize applicants with limited access to other resources such as institutional support packages. Funds can be used to “buy out” clinical obligations or to hire additional research staff to optimize research activities. Applicants must have a compelling, time-sensitive need for the funds to regain research momentum because of increased family caregiving responsibilities caused by the COVID-19 pandemic. Typically, this would be childcare, partner care, and/or eldercare, but applicants may make the case for other reasonable family caregiving responsibilities.

Key Dates

  • Application due date: October 31, 2022
  • Earliest anticipated start date: December 1, 2022


  • Applicants must have a full-time faculty appointment at the Yale School of Medicine as Assistant Professor or Instructor at the time of the award.
  • Applicants may not have been a faculty member for more than 10 years by the anticipated start date of December 1, 2022. The 10-year period is cumulative and includes all appointments as assistant professor, associate research scientist, lecturer, or instructor at any institution (any part-time appointments and leaves of absence should be described and will be considered in calculating the total time at a faculty rank).
  • Applicants must have an MD or a DO degree and must have a current US medical license.
  • Applicants must demonstrate a compelling need for the supplement that is related to being a caregiver.
  • Applicants must have an active intra or extramural career development award or research project grant with annual direct costs sufficient to provide both research and salary support. Internal start-up funds do not satisfy this requirement.
  • Applicants must have a minimum of 50% effort allocation to research at the time of application.
  • Applicants must show evidence of strong research training and productivity.
  • Applicants must be conducting an original and rigorous clinical research project that has the potential to address a health issue that poses a significant clinical burden (with considerable morbidity and mortality, whether it is a rare or common condition) and that has potential for societal benefit. Clinical research is defined as the scientific investigation of the etiology, prevention, diagnosis, or treatment of human disease using human subjects, human populations, or materials of human origin. Included in the definition are studies that utilize tissues or pathogens only if they can be linked to a patient.
  • Previous awardees may request a second year of support in select circumstances if well-justified and if previously awarded funds have been expended by the anticipated start date.

Award Information

Accessibility Assistance

For assistance with these documents, please contact Nicholas Licht.


  • Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

    Dr. Linda Bockenstedt is the Harold W. Jockers Professor of Medicine, Section of Rheumatology, and Deputy Dean for Faculty Affairs at Yale School of Medicine. She received her undergraduate degree in chemistry and physics from Harvard College and is a graduate of the Ohio State University School of Medicine. After completing residency training in medicine and serving as Chief Resident in Medicine at Yale, Dr. Bockenstedt obtained rheumatology clinical and research fellowship training at the University of California, San Francisco. She has been a faculty member at Yale School of Medicine since 1989, where she directs a research program devoted toward understanding the pathogenesis of Lyme disease, an infection-related rheumatic disease. Her research has been continually supported by the National Institutes of Health since 1990, and she is internationally recognized for her studies of the host immune response to spirochetal infection. As a physician-scientist, she also is an active clinician and educator for medical trainees. Dr. Bockenstedt is a Master of the American College of Rheumatology, and an elected member of the Kunkel Society and the Interurban Clinical Club. She is a former standing member of the Immunity and Host Defense Study Section at NIH and former member of the Board of Directors for the American College of Rheumatology Research & Education Foundation. She currently serves on the NIH NIAID Council and the DOD Tick-Borne Disease Research Program Programmatic Panel. Since 2006 she has been active in faculty affairs at Yale School of Medicine and in 2017, was appointed YSM Deputy Dean for Academic Affairs.
  • Aaron B. and Marguerite Lerner Professor and Chair of Dermatology. Professor of Genetics and Pathology. Associate Dean for Physician-Scientist Development

    Keith Choate M.D., Ph.D., is a physician-scientist who employs tools of human genetics to understand fundamental mechanisms of disease. His laboratory studies rare inherited and mosaic skin disorders to identify novel genes responsible for epidermal differentiation and development.  His laboratory has identified the genetic basis of over 12 disorders and has developed new therapeutic approaches informed by genetic findings.  His laboratory is funded by the National Institute of Arthritis and of Musculoskeletal and Skin Diseases, a division of the National Institutes of Health.Dr. Choate mentors undergraduate, graduate, and medical students in his laboratory, teaches at Yale Medical School, and trains resident physicians and fellows.